Literature DB >> 18612886

Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study.

Li-Tzy Wu1, Dan G Blazer, Maxine L Stitzer, Ashwin A Patkar, Jack D Blaine.   

Abstract

We sought to determine the prevalence, patterns, and correlates of past-month illicit methadone use and history of regular illicit use among stimulant-using methadone maintenance treatment patients. We obtained self-reported information on illicit methadone use from 383 participants recruited from six community-based methadone maintenance programs. Overall, 1.6% of participants reported illicit use in the past month, and 4.7% reported a history of regular use. Younger age and history of outpatient psychological treatment were associated with increased odds of past-month illicit use. Illicit methadone use among patients in maintenance programs is infrequent; however, a number of factors may increase risk of illicit use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612886      PMCID: PMC2746380          DOI: 10.1080/10550490802138913

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  22 in total

1.  Use of illegally acquired medical opioids by opiate-dependent patients in detoxification treatment.

Authors:  N Scherbaum; J Kluwig; C Meiering; M Gastpar
Journal:  Eur Addict Res       Date:  2005       Impact factor: 3.015

2.  Diversion and abuse of methadone prescribed for pain management.

Authors:  Theodore J Cicero; James A Inciardi
Journal:  JAMA       Date:  2005-01-19       Impact factor: 56.272

3.  Methods of detoxification and their role in treating patients with opioid dependence.

Authors:  Patrick G O'Connor
Journal:  JAMA       Date:  2005-08-24       Impact factor: 56.272

4.  Methadone injecting in Australia: a tale of two cities.

Authors:  N Lintzeris; M Lenné; A Ritter
Journal:  Addiction       Date:  1999-08       Impact factor: 6.526

5.  Illicit use of methadone among i.v. drug users in Montreal.

Authors:  P Lauzon; J Vincelette; J Bruneau; F Lamothe; N Lachance; M Brabant; J Soto
Journal:  J Subst Abuse Treat       Date:  1994 Sep-Oct

6.  A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

Authors:  V P DOLE; M NYSWANDER
Journal:  JAMA       Date:  1965-08-23       Impact factor: 56.272

Review 7.  Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions.

Authors:  W S Condelli; J A Fairbank; M L Dennis; J V Rachal
Journal:  J Subst Abuse Treat       Date:  1991

Review 8.  Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction.

Authors: 
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272

9.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08

10.  The use of the DSM-III-R Checklist for initial diagnostic assessments.

Authors:  J J Hudziak; J E Helzer; M W Wetzel; K B Kessel; B McGee; A Janca; T Przybeck
Journal:  Compr Psychiatry       Date:  1993 Nov-Dec       Impact factor: 3.735

View more
  8 in total

1.  An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study.

Authors:  Li-Tzy Wu; Jeng-Jong Pan; Dan G Blazer; Betty Tai; Maxine L Stitzer; Robert K Brooner; George E Woody; Ashwin A Patkar; Jack D Blaine
Journal:  J Stud Alcohol Drugs       Date:  2009-05       Impact factor: 2.582

2.  A systematic scoping review of research on Black participants in the National Drug Abuse Treatment Clinical Trials Network.

Authors:  LaTrice Montgomery; Ann Kathleen Burlew; Angela M Haeny; Chizara A Jones
Journal:  Psychol Addict Behav       Date:  2019-06-27

3.  Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.

Authors:  Shannon Gwin Mitchell; Sharon M Kelly; Barry S Brown; Heather Schacht Reisinger; James A Peterson; Adrienne Ruhf; Michael H Agar; Kevin E O'Grady; Robert P Schwartz
Journal:  Am J Addict       Date:  2009 Sep-Oct

4.  The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study.

Authors:  Li-Tzy Wu; Jeng-Jong Pan; Dan G Blazer; Betty Tai; Robert K Brooner; Maxine L Stitzer; Ashwin A Patkar; Jack D Blaine
Journal:  Drug Alcohol Depend       Date:  2009-05-06       Impact factor: 4.492

5.  Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study.

Authors:  Li-Tzy Wu; Dan G Blazer; Ashwin A Patkar; Maxine L Stitzer; Paul G Wakim; Robert K Brooner
Journal:  Am J Addict       Date:  2009 May-Jun

6.  The national drug abuse treatment clinical trials network data share project: website design, usage, challenges, and future directions.

Authors:  Dikla Shmueli-Blumberg; Lian Hu; Colleen Allen; Michael Frasketi; Li-Tzy Wu; Paul Vanveldhuisen
Journal:  Clin Trials       Date:  2013-10-01       Impact factor: 2.486

7.  A Prospective Study to Investigate Predictors of Relapse among Patients with Opioid Use Disorder Treated with Methadone.

Authors:  Leen Naji; Brittany B Dennis; Monica Bawor; Carolyn Plater; Guillaume Pare; Andrew Worster; Michael Varenbut; Jeff Daiter; David C Marsh; Dipika Desai; Lehana Thabane; Zainab Samaan
Journal:  Subst Abuse       Date:  2016-04-10

8.  Pain Appraisals in Patients with Physical Injury: Assessing the Role of Distress Tolerance in the Relationship between Depression and Pain Catastrophizing.

Authors:  Valerie J Hruschak; Yan Yuan; Whitney Ringwald; Corinne Beaugard; Melissa Repine; Maria Pacella-LaBarbara; Daniel Rosen; Gerald Cochran
Journal:  Health Soc Work       Date:  2021-08-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.